Fundraising FoxHealthCap — 2015 Investments
3 investments dated 2015 · listed companies and verified rows first · show all
Pulmonx develops the Zephyr Valve, a bronchoscopic device used to treat patients with severe COPD/emphysema without surgery.
BiotechHealthtechMedical DevicesSan Jose, US
LAUREN CRISTINA(Executive Officer)inSri Radhakrishnan(Chief Technology Officer)inMICHAEL BAKER(Executive Officer, Director)inGlendon E. French(Chief Executive Officer and Director)Derrick Sung(Chief Operating Officer and Chief Financial Officer)inGeoffrey Beran Rose(Chief Commercial Officer)
Board seatStaffan Lindstrand· per SEC Form D
Co-investorsBand of AngelsKaiser Permanente VenturesKleiner PerkinsLatterell Venture PartnersMontreux Equity PartnersAlly Bridge Group
BiotechRaleigh, US
Jaikrishna Patel(Executive Officer)Pierre Legault(Executive Officer, Director)inJames Mitchum(Director)John Hamill(Executive Officer)in
BoardRobert Seltzer(Director)
Board seatEugen Steiner· per SEC Form D · $28.5M raise · filed Nov 2015
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Cerenis Therapeutics Holding S.A
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.